New evidence shows that in MM cell lines that the sensitivity to EZH2 inhibitor correlated with distinct metabolic signatures resulting from a dysregulation of genes involved in methionine cycling [99]. This evidence concerns the gene EZH2 and Miyoshi myopathy.